🧠 Watchlist Wednesday: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Benitec Biopharma Ltd ADR (BNTC)

NASDAQ
Currency in USD
Disclaimer
8.750
-0.120(-1.35%)
Closed

BNTC Cash Flow Statement

Advanced Cash Flow Statement
Period Ending:
2014
30/06
2015
30/06
2016
30/06
2017
30/06
2018
30/06
2019
30/06
2020
30/06
2021
30/06
2022
30/06
2023
30/06
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa4.79-7.54-12.83-15.9-18.01
Cash from Operations Growth
Net Income
Depreciation & Amortisation, Total
Amortisation of Deferred Charges, Total
Other Non-Cash Items, Total
Change in Net Operating Assets
aa.aaaa.aaaa.aaaa.aaaa.aa+166.05%-257.31%-70.3%-23.9%-13.29%
aa.aaaa.aaaa.aaaa.aaaa.aa2.61-8.27-13.88-18.21-19.56
aa.aaaa.aaaa.aaaa.aaaa.aa0.160.370.420.390.38
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa0.70.240.620.880.46
aa.aaaa.aaaa.aaaa.aaaa.aa1.320.130.011.040.71
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-0.4-0.09-0.22-0.01-0
Cash from Investing Growth
Capital Expenditure
Sale of Property, Plant, and Equipment
Cash Acquisitions
Divestitures
Other Investing Activities
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-1.7722.52-16.02
Cash from Financing Growth
Total Debt Issued
Short Term Debt Issued, Total
Long-Term Debt Issued, Total
Total Debt Repaid
Short Term Debt Repaid, Total
Long-Term Debt Repaid, Total
Issuance of Common Stock
Repurchase of Common Stock
Issuance of Preferred Stock
Repurchase of Preferred Stock
Common & Preferred Stock Dividends Paid
Special Dividend Paid
Other Financing Activities
Foreign Exchange Rate Adjustments
Miscellaneous Cash Flow Adjustments
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa3.84-5.929.97-15.71-1.59
Beginning Cash Balance
Cash And Equivalents
Levered Free Cash Flow
Levered Free Cash Flow Growth
Free Cash Flow Yield
aa.aaaa.aaaa.aaaa.aaaa.aa11.8815.729.819.774.06
aa.aaaa.aaaa.aaaa.aaaa.aa15.729.819.774.062.48
aa.aaaa.aaaa.aaaa.aaaa.aa3.21-4.33-7.28-8.72-10.19
aa.aaaa.aaaa.aaaa.aaaa.aa+179.5%-234.78%-68.36%-19.78%-16.74%
aa.aaaa.aaaa.aaaa.aaaa.aa45.57-94.46-71.5-167.86-320.58
* In Millions of USD (except for per share items)